These data along with pharmacological data indicate that bleomycin triggers complex, multifactorial (TGFβ dependent and independent) responses that result in pathophysiological changes in mice that are consistent with IPF. The gene discussed is TGFB1; the disease is idiopathic pulmonary fibrosis.